What You Should Know:
- Strive Health, a Denver-based provider of value-based kidney care today announced $140 million in Series B funding with Alphabet’s independent growth fund, CapitalG, as the lead investor. Strive has more than doubled its presence in regional markets and grown its employee base by more than 600% in the last year. This funding will further increase that momentum.
- Currently, there is $410 billion of unmanaged kidney disease
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know:
- Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
- Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
Unite Us Nabs $150M, Reaching $1.6B Valuation to Address Social Determinants of Health
What You Should Know:
- Unite Us, the tech company creating coordinated care networks nationwide, has just announced a $150M Series C round of funding led by ICONIQ Capital, bringing its valuation at $1.65 billion.
- Unite Us is leading the care transformation movement towards whole-person health with its core product, Unite Us Platform, an outcome-focused coordination software sconnecting community-based organizations with health care providers, health plans,
Read More
AI-Powered COVID-19 Solution Reduces Report Turnaround Times by 30%, Study Finds
What You Should Know:
- The Moscow Center for Diagnostics & Telemedicine found that the introduction of RADLogics’ AI-Powered solution into radiology workflow to analyze Chest-CT scans during the COVID-19 pandemic reduced report turnaround time by an average of 30 percent, which is equivalent to 7 minutes per case.
- The study was conducted over two separate phases with the first taking place between April 30, 2020 to June 18, 2020 and the second taking place between June 18, 2020 to
Read More
Variantyx Lands $20M for Whole Genome Sequencing Methodology
What You Should Know:
- Variantyx, a Boston-based provider of high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango
Read More
Waystar Launches Price Transparency Solutions to Meet Consumer Demand
What You Should Know:
- Waystar, a provider of healthcare payments software, today announced the addition of the Text Statements feature to its suite of payment tools. This new solution enables patients to easily view and pay medical bills directly from their smartphone, bringing transparency and convenience to the patient financial experience – a long-standing focus for Waystar.
- Patients frequently don’t know what they’ll owe weeks, if not months after the point of care, If
Read More
MEDITECH Expanse Leads Customer Satisfaction for Small Community Hospitals, KLAS Report Finds
What You Should Know:
- Small community hospitals (1–200 beds) leaders cite MEDITECH Expanse Acute Care EMR as a leader in delivering the most consistent customer experience, according to a new KLAS report.
The KLAS report reveals that while Epic and Cerner EMRs leads in performance among large organizations they don’t deliver as consistently for smaller hospitals. Customers cite their approaches to the community market—hub-and spoke relationship (Epic) and shared server (Cerner)—create
Read More
BioIntelliSense Partners with Leukemia & Lymphoma Society for Continuous Monitoring in Clinical Trials
What You Should Know:
-BioIntelliSense announced it has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate the BioSticker™ platform in clinical trials of hematological cancer patients.
- The LLS clinical trials will include use of the BioSticker medical device for the continuous collection of vital sign and physiological data which includes temperature, heart rate, respiratory rate at rest, activity level and body position. The BioSticker
Read More
City of Milwaukee Taps NowPow to Improve Health Equity & Outcomes
What You Should Know:
- IMPACT, a designated provider of 211 information and referral services in Southeastern Wisconsin, today announced a groundbreaking collaboration with local health systems, community organizations and NowPow to power one of the nation’s most comprehensive, community-wide systems to connect health and social care and track outcomes.
- As part of the partnership, IMPACT Connect will establish a shared digital platform for partner organizations across multiple sectors —
Read More
Exscientia Secures $100M To Expand AI Drug Discovery Platform
What You Should Know:
- Exscientia, leading AI drug discovery company, today announced that it completed its $100 million Series C financing round, with a further $30 million investment from Blackrock.
- This new capital, which will be used to support Exscientia's platform development and proprietary pipeline, follows Exscientia’s demonstrated high growth, having announced earlier this year that the first ever precision engineered drug designed using AI had entered Phase I human clinical
Read More
